Effects of β-casomorphin-5 on passive avoidance response in mice

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 11, 2003, Pages 2501-2504

  Sakaguchi, Minoru ^a   Koseki, Makoto ^a   Wakamatsu, Masanori ^a   Matsumura, Eiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

casomorphin 5; opioid receptor; Passive avoidance response; Scopolamine; Step down latency

Indexed keywords

BOVINAE;

ANALGESIC AGENT; BETA CASOMORPHINE 5; BETA FUNALTREXAMINE; BETA-CASOMORPHIN 5; BETA-FUNALTREXAMINE; DRUG DERIVATIVE; ENDORPHIN; NALTREXONE; NARCOTIC ANTAGONIST; PEPTIDE FRAGMENT; SCOPOLAMINE;

ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN VENTRICLE; DRUG ANTAGONISM; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; MOUSE STRAIN; PHYSIOLOGY; REACTION TIME;

ANALGESICS; ANIMALS; AVOIDANCE LEARNING; CEREBRAL VENTRICLES; ENDORPHINS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED STRAINS; NALTREXONE; NARCOTIC ANTAGONISTS; PEPTIDE FRAGMENTS; REACTION TIME; SCOPOLAMINE;

EID: 3242891706     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.67.2501     Document Type: Article

References (24)

1. Brantl, V., Teschemacher, H., Henschen, A., and Lottspeich, F., Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Z Physiol. Chem., 360, 1211-1216 (1979).
2. Brantl, V., Teschemacher, H., Blasig, J., Henschen, A., and Lottspeich, F., Opioid activities of β-casomorphins. Life Sci., 28, 1903-1909 (1981).
3. Brantl, V., Pfeiffer, A., Herz, A., Menschen, A., and Lottspeich, F., Antinociceptive potencies of β-casomorphin analogs as compared to their affinity toward μ and δ-opiate receptor sites in brain and periphery. Peptides, 3, 793-797 (1982).
4. 2): A potent and specific agonist for morphine (μ) recetpor. Science, 212, 75-77 (1981).
5. Chang, K.-J., Cuatrecasas, P., Wei, E. T., and Chang, J.-K., Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: Correlation with the morphin (μ) receptor binding affinity. Life Sci., 30, 1547-1552 (1982).
6. Izquierdo, I., and Netto, C. A., Role of β-endorphin in behavioral regulation. Ann. N. Y. Acad. Sci., 444, 162-177 (1985).
7. Rigter, H., Hannan, T. J., Messing, R. B., Martinez, J. L. Jr., Vasquez, B. J., Jensen, R. A., Veliquette, J., and McGaugh, J. L., Enkephalins interfere with acquisition of an active avoidance response. Life Sci., 26, 337-345 (1979).
8. Itoh, J., Ukai, M., and Kameyama, T., Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther., 269, 15-21 (1994).
9. Takahashi, M., Fukunaga, H., Kaneto, H., Fukudome, S., and Yoshikawa, M., Behavioral and pharmacological studies on gluten exorphin A5, a newly isolated bioactive food protein fragment, in mice. Jpn. J. Pharmacol., 84, 259-265 (2000).
10. 25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience, 83, 413-428 (1998).
11. Ukai, M., Watanabe, Y., and Kameyama, T., Endomorphins-1 and -2, endogenous μ-opioid receptor agonists, impair passive avoidance learning in mice. Eur. J. Pharm., 421, 115-119 (2001).
12. McGaugh, J. L., and Cahill, L., Interaction of neuromodulatory systems in modulating memory storage. Behav. Brain Res., 83, 31-38 (1997).
13. 1-opioid receptor in mice. NeuroReport, 12, 3723-3727 (2001).
14. Ukai, M., Watanabe, Y., and Kameyama, T., Effects of endomorphins-1 and -2, endogenous μ-opioid receptor agonists, on spontaneous alternation performance in mice. Eur. J. Pharm., 395, 211-215 (2000).
15. Ragozzino, M. E., Wenk, G. L., and Gold, P. E., Glucose attenuates a morphine-induced decrease in hippocampal acetylcholine output: an in vivo microdialysis study in rats. Brain Res., 655, 77-82 (1994).
16. Introini, I. B., and Baratti, C. B., The impairment of retention induced by β-endorphin in mice may be mediated by reduction of central cholinergic activity. Behav. Neural. Biol., 41, 152-163 (1984).
17. s-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci., 19, 358-365 (1998).
18. Ukai, M., and Lin, H. P., Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice. Eur. J. Pharm., 446, 97-101 (2002).
19. Wagner, J. J., Etemad, L. R., and Thompson, A. M., Opioid-mediated facilitation of long-term depression in rat hippocampus. J. Pharmacol. Exp. Ther., 296, 776-781 (2001).
20. Kovács, G. L., and De Wied, D., Peptidergic modulation of learning and memory processes. Pharmacol. Rev., 46, 269-291 (1994).
21. Mentlein, R., Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett., 234, 251-256 (1988).
22. Wilk, S., Prolyl endopeptidase. Life Sci., 33, 2149-2157 (1983).
23. Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H., and Tsuru, D., Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. Pharmacobiodyn., 10, 730-735 (1987).
24. Asano, M., Nio, N., and Ariyoshi, Y., Inhibition of prolyl endopeptidase by synthetic./;casein peptides and their derivatives with a C-terminal prolinol or prolinal. Biosci. Biotechnol. Biochem., 56, 976-977 (1992).